Product Details
Product Sizes
Size | List Price | Price | Cart |
---|---|---|---|
100 ug | $365.00 | Add to Cart |
Toll-Like Receptor 4 (TLR4) has been identified next to MD2 and CD14 as a receptor that is central to the innate immune response to lipopolysaccharides (LPS) of Gram negative bacteria. TLR4 contributes to the initiation of CNS neuroimmune activation after nerve transection. TLR4 is part of an early, specific, innate CNS/microglial response and maybe relevant in the prevention and treatment of neuropathic pain syndromes. TLR4 is weakly expressed by resting cells, but is upregulated following stimulation with LPS. |
- Product Reviews
Leave a review for this product and you could be eligible for a $10 Starbucks gift card.
- Product Publications
Product Publications
If you've used this product in a publication, let us know. Email rose@neuromics.com, with the publication details and you could be eligible for an Amazon gift card.
- Related Products
Related Products
Images
Toll-Like Receptor 4 (TLR4 or CD284) staining of immersion fixed paraffin-embedded sections of human prostate at 10 µg/mL overnight at 4 °C. Before incubation with the primary antibody tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent. Tissue was stained using the Anti-Goat HRP-DAB. (brown) and counterstained with hematoxylin (blue).
Toll-Like Receptor 4 (TLR4 or CD284) staining of immersion fixed paraffin-embedded sections of human prostate at 10 µg/mL overnight at 4 °C. Before incubation with the primary antibody tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent. Tissue was stained using the Anti-Goat HRP-DAB. (brown) and counterstained with hematoxylin (blue).
Figure 1: Lipopolysacharide (LPS) induces IL-8 secretion in HEK293 cells transfected with hTLR4/hMD-2 (293-hTLR4/hMD-2) in a dose dependant manner. Figure 2: To measure the ability of this antibody to neutralize the TLR4-mediated LPS response on 293-hTLR4/hMD-2 cells, various concentrations of this antibody were incubated with 293-hTLR4/hMD-2 cells in a 96-well plate for 1 hour at 37° C.
Figure 1: Lipopolysacharide (LPS) induces IL-8 secretion in HEK293 cells transfected with hTLR4/hMD-2 (293-hTLR4/hMD-2) in a dose dependant manner. Figure 2: To measure the ability of this antibody to neutralize the TLR4-mediated LPS response on 293-hTLR4/hMD-2 cells, various concentrations of this antibody were incubated with 293-hTLR4/hMD-2 cells in a 96-well plate for 1 hour at 37° C.